Connection
Stephen Waldo to Drug-Eluting Stents
This is a "connection" page, showing publications Stephen Waldo has written about Drug-Eluting Stents.
|
|
Connection Strength |
|
 |
|
 |
|
0.673 |
|
|
|
-
Kokkinidis DG, Prouse AF, Avner SJ, Lee JM, Waldo SW, Armstrong EJ. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2018 08 01; 92(2):285-299.
Score: 0.137
-
Waldo SW, O'Donnell CI, Prouse A, Plomondon ME, Rao SV, Maddox TM, Ho PM, Armstrong EJ. Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program. Catheter Cardiovasc Interv. 2018 02 15; 91(3):425-433.
Score: 0.134
-
Kokkinidis DG, Waldo SW, Armstrong EJ. Treatment of coronary artery in-stent restenosis. Expert Rev Cardiovasc Ther. 2017 Mar; 15(3):191-202.
Score: 0.131
-
Armstrong EJ, Bishu K, Waldo SW. Endovascular Treatment of Infrapopliteal Peripheral Artery Disease. Curr Cardiol Rep. 2016 Apr; 18(4):34.
Score: 0.123
-
Yeo KK, Armstrong EJ, Soni K, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI, Shunk KA, Mahmud E, Rogers JH. Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry. EuroIntervention. 2015 Jun; 11(2):188-95.
Score: 0.116
-
Wiktor DM, Waldo SW, Armstrong EJ. Coronary Stent Failure: Fracture, Compression, Recoil, and Prolapse. Interv Cardiol Clin. 2016 07; 5(3):405-414.
Score: 0.031
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|